On May 23rd, Hang Seng Indexes Company Launches Hang Seng China Metaverse Index and the Hang Seng Shanghai-Shenzhen-Hong Kong Genomics and Oncology Index. These two indexes are created to capture the performance of companies that deal with Metaverse, Genomics, and Oncology concepts, which have become increasingly popular among investors.
The Hang Seng Composite LargeCap & MidCap Index, as well as A-shares eligible for Northbound trading under the Stock Connect Scheme, are included in the indexes universe.
Tencent Holdings Ltd, NetEase, Inc, Kuaishou Technology, Goertek Inc., and Sunny Optical Technology (Group) Company Limited are the top five constituent companies of the Hang Seng China Metaverse Index, as of May 17th.
Wuxi Apptec Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co., Ltd, CSPC Pharmaceutical Group Limited, Shanghai Junshi Biosciences Co., Ltd., and Shanghai Fosun Pharmaceutical (Group) Co., Ltd are the top five constituent companies of Hang Seng Shanghai-Shenzhen-Hong Kong Genomics and Oncology Index, as of May 17th.
Daniel Wong, Director & Chief Index Officer at Hang Seng Index’s Company, believes the establishment of these two indexes is significant and they will serve as guidelines to assist investors in seizing the opportunity, especially in megatrends like these.